Abstract

Alzheimer’s disease (AD) is an incurable form of dementia affecting millions of people worldwide and costing billions of dollars in health care-related payments, making the discovery of a cure a top health, societal, and economic priority. Peptide-based drugs and immunotherapies targeting AD-associated beta-amyloid (Aβ) aggregation have been extensively explored; however, their therapeutic potential is limited by unfavorable pharmacokinetic (PK) properties. Peptoids (N-substituted glycine oligomers) are a promising class of peptidomimetics with highly tunable secondary structures and enhanced stabilities and membrane permeabilities. In this review, the biological activities, structures, and physicochemical properties for several amyloid-targeting peptoids will be described. In addition, metal-chelating peptoids with the potential to treat AD will be discussed since there are connections between the dysregulation of certain metals and the amyloid pathway.

Highlights

  • Alzheimer’s disease (AD) is an incurable form of dementia afflicting an estimated 5.5 millionAmericans [1]

  • This review presents the structures, methods biological activities, and physicochemical properties for various antiamyloidogenic peptoids.used, In addition, several metal-chelating peptoids are properties for various antiamyloidogenic peptoids

  • Emerging evidence suggests soluble aggregates rather fibrils are responsible for AD-associated neurotoxicity, which has led to a shift in approach in than fibrils are responsible for AD-associated neurotoxicity, which has led to a shift in approach in anti-amyloid drug drug design design [35,36]

Read more

Summary

Introduction

Alzheimer’s disease (AD) is an incurable form of dementia afflicting an estimated 5.5 million. Challenges surrounding AD drug discovery include mis-diagnosis of clinical trial patients [10,11,12], a lack of reliable biomarkers [10], and an incomplete understanding of the complex and multifaceted disease pathology involving tau hyper-phosphorylation, Aβ aggregation, cholinergic dysfunction, metal dysregulation, inflammation, and oxidative stress [3,6,13,14], which are often interconnected. Peptoids (N-substituted glycine oligomers; [16]) have emerged as a promising class of peptidomimetics [17] with a range of properties, including anti-cancer [18] and antibacterial. This review presents the structures, methods biological activities, and physicochemical properties for various antiamyloidogenic peptoids.used, In addition, several metal-chelating peptoids are properties for various antiamyloidogenic peptoids. The medicinal of peptide and peptoid foldamers, of peptide andinteractions, peptoid foldamers, including antibacterial properties and The theirmedicinal abilities toproperties disrupt protein-protein have been reviewed [19,20]. Kodadek and Vanderstichele [31] and will not be discussed here

Amyloid-Targeting Peptoids
Peptoid-Based Aβ1–42 -Aggregation Inhibitors
Peptoid-Based Aβ1–40 -Aggregation Inhibitors
Peptoids Targeting the Apolipoprotein E4-Aβ Interaction
Comparative Structure-Activity Relationship for Amyloid-Targeting Peptoids
Metal-Chelating Peptoids
Screening Approaches for the Discovery of Metal-Binding Peptoids
Comparative Structure-Activity Relationship for Metal-Chelating Peptoids
Advantages of Metal-Chelating Peptoids
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call